Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Sacituzumab tirumotecan (sac-TMT), an antibody-drug conjugate, is currently being evaluated in combination with the immunotherapy pembrolizumab as a first-line treatment for patients with metastatic or locally advanced PD-L1-positive triple-negative breast ... Read More
Continuous Coverage
In the shadow of a rapidly shifting geopolitical landscape, Japan’s defense minister has issued a pointed rebuke to…
Doctors suggest lifestyle changes that may lower HbA1c by 1.5% in 90 days, according to recent reports. These…
Following a surge in sideline abuse against rugby referees, their families are avoiding matches, raising urgent questions about…
British filmmaker Chris West’s latest visual experiment, *West In Pics*—a surreal, high-energy short film blending stop-motion sheep, CGI…
Google (NASDAQ: GOOGL) is rewriting the internet’s architecture by embedding AI into its core search infrastructure, accelerating a…
A fireball streaked over the northeastern United States late Tuesday, detonating with the force of 300 tons of…
Global Affairs
Vietnam’s taekwondo team has just claimed two gold medals in poomsae at the 2026 Asian Championships, marking the…
Markets And Money
China’s official manufacturing Purchasing Managers’ Index (PMI) hit 50.0 in May 2026, signaling a stagnant industrial sector. Hovering…
Digital Culture
A critical buffer overflow vulnerability in 7-Zip, tracked as CVE-2024-43610, allows attackers to achieve arbitrary code execution simply…
Science And Wellbeing
Argentina has successfully contained the recent localized outbreak of Hantavirus, a zoonotic pathogen transmitted primarily through rodent excreta.…
Screen And Sound
When “Masha and the Bear” faced bans in Iran, critiques in the U.S., and Canadian backlash, it sparked…
Fixtures And Form
Chilean fans eyeing the 2026 FIFA World Cup Panini album face a $440,000 challenge, with price strategies and…
